PULCINELLI, FABIO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 5.671
EU - Europa 2.723
AS - Asia 1.118
SA - Sud America 155
AF - Africa 42
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.714
Nazione #
US - Stati Uniti d'America 5.623
IT - Italia 1.488
SG - Singapore 675
IN - India 231
UA - Ucraina 212
SE - Svezia 191
FI - Finlandia 181
CN - Cina 157
DE - Germania 143
RU - Federazione Russa 116
BR - Brasile 97
AT - Austria 66
IE - Irlanda 64
GB - Regno Unito 62
FR - Francia 51
BG - Bulgaria 48
AR - Argentina 45
CA - Canada 42
NL - Olanda 35
TG - Togo 28
ID - Indonesia 21
BE - Belgio 20
RO - Romania 13
HK - Hong Kong 8
CH - Svizzera 7
CL - Cile 5
EG - Egitto 5
LT - Lituania 5
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
MX - Messico 3
RS - Serbia 3
AL - Albania 2
AU - Australia 2
BD - Bangladesh 2
CO - Colombia 2
ES - Italia 2
EU - Europa 2
HR - Croazia 2
LU - Lussemburgo 2
MY - Malesia 2
PL - Polonia 2
SA - Arabia Saudita 2
SN - Senegal 2
TR - Turchia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
TN - Tunisia 1
TW - Taiwan 1
Totale 9.714
Città #
Fairfield 769
Chandler 546
Rome 514
Woodbridge 410
Ashburn 369
Singapore 345
Houston 306
Seattle 302
Wilmington 273
Ann Arbor 258
Cambridge 254
Dearborn 252
Princeton 142
Plano 111
New York 109
Lawrence 87
San Paolo di Civitate 87
Santa Clara 87
Boston 86
Jacksonville 84
Fremont 73
Milan 65
Dublin 64
Vienna 64
Helsinki 58
Beijing 52
San Diego 52
Millbury 46
Federal 42
Sofia 42
Boardman 37
Andover 34
Cosenza 30
Toronto 29
Lomé 28
Moscow 25
Norwalk 24
Jakarta 21
Brussels 19
Lappeenranta 19
Falkenstein 18
Naples 18
Des Moines 17
Falls Church 17
Bühl 13
Nuremberg 13
San Mateo 13
Verona 13
Hefei 12
Yubileyny 12
Council Bluffs 11
Nanjing 11
Ottawa 11
Palermo 11
Bologna 10
Washington 10
Grafing 9
Guangzhou 9
Kunming 9
Latina 9
Bari 8
Campobasso 8
São Paulo 8
Vercelli 8
Fiuggi 7
Mannheim 7
Amsterdam 6
Auburn Hills 6
Bremen 6
Calvenzano 6
Castel Maggiore 6
Catania 6
Florence 6
Francavilla Fontana 6
Hong Kong 6
Jinan 6
Paris 6
Pune 6
Southend 6
Belo Horizonte 5
Buffalo 5
Castelnuovo Rangone 5
Cernobbio 5
Dallas 5
Los Angeles 5
Nanchang 5
Napoli 5
Padova 5
Perugia 5
Redmond 5
Reggio Calabria 5
Sant'Antonio Abate 5
Torino 5
Vignanello 5
Bern 4
Brescia 4
Frankfurt am Main 4
Hyderabad 4
London 4
Phoenix 4
Totale 6.684
Nome #
Efficacia e tollerabilità della doppia terapia antiaggregante piastrinica con Indobufene e Clopidogrel in pazienti con SCA e allergia documentata all’aspirina, sottoposti a PTCA ed impianto di stent 331
Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention. 174
Efficacia e tollerabilità dell’associazione indobufene-clopidogrel dopo PTCA ed impianto di stent medicato in pazienti con intolleranza od allergia all’ASA 150
Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA covid-19 vaccine 135
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients. Another COVID-19 paradox 130
Efficacia e tollerabilità della doppia antiaggregazione piastrinica clopidogrel-indobufene in pz con SCA e allergia documentata all’aspirina, sottoposti a PTCA e stenting 126
(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition 126
Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment 118
Vaccine-induced immune thrombotic thrombocytopenia and spike protein 113
ACID CITRATE DEXTROSE (ACD) FORMULA-A AS A NEW ANTICOAGULANT IN THE MEASUREMENT OF IN-VITRO PLATELET-AGGREGATION 112
HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer 111
Impact of Multidrug Resistance Protein-4 Inhibitors on Modulating Platelet Function and High on-Aspirin Treatment Platelet Reactivity 107
From human Megakaryocytes to platelets: Effects of aspirin on high-mobility group Box 1/receptor for advanced glycation end products axis 106
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19 105
Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease 103
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study 102
Aspirin does not equally inhibit thromboxane A2 formation in long-term treated patients 102
Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress 101
Multidrug Resistance Protein-4 influences aspirin toxicity in human cell line 99
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2 98
Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment 98
Aspirin resistance: position paper of the Working Group on Aspirin Resistance. 98
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia 97
Concomitant activation of Gi and Gq protein-coupled receptors does not require an increase in cytosolic calcium for platelet aggregation. 97
Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets 96
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein 95
Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets 94
Differential platelet proaggregating activity of three Burkitt's lymphoma-derived human cell lines. 93
Involvement of the glycoproteic Ib-V-IX complex in nickel-induced platelet activation. 93
Concomitant activation of Gi protein-coupled receptor and Protein kinase C or Phospholipase C is required for platelet aggregation. 92
Clinical course, management, and platelet activity assessment of splanchnic VITT: a case report 90
MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation 89
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia 89
Administration of minor polar compound-enriched extra virgin olive oil decreases platelet aggregation and the plasma concentration of reduced homocysteine in rats1 88
Celecoxib induces MRP-4 in lung cancer cells: Therapeutic implications 88
Increased von willebrand factor platelet-binding capacity is related to poor prognosis in Covid-19 patients 83
Human platelet lysate‐derived extracellular vesicles enhance angiogenesis through miR‐126 83
Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets. 83
New platelet functional method for identification of pathogenic antibodies in HIT patients 83
Celecoxib upregulates multidrug resistance proteins in colon cancer: Lack of synergy with standard chemotherapy 83
Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination 83
Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets 82
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients. 82
Aspirin-dependent effects on purinergic P2Y1 receptor express 82
Blood cellular and biochemical changes after extracorporeal shock wave lithotripsy. 81
Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment 81
Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport 81
Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure 79
IN-VIVO THROMBIN GENERATION AND PLATELET HYPERACTIVITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 79
A method to prepare degranulated platelets: use for studies of platelet aggregation and CA2+ mobilization. 78
Nickel enhances collagen-induced platelet activation acting by increasing the organization of the cytoskeleton 78
Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production 77
Mechanism of the persisting TxA2 receptor antagonism by picotamide. 75
MiR-21 role in aspirin-dependent PPARα and MRP4 up-regulation 75
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated 75
Collagen-induced platelet thromboxane A2 production in patients chronically treated with aspirin 73
Blood leukotrienes in headache: correlation with platelet activity. 73
Effects of Pomegranate Juice and Extract Polyphenols on Platelet Function 73
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. A rebuttal. 72
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 72
DAG induces Ca2+ influx through NCKX-TRPC interaction, independently on PKC activity The International Society on thrombosis and haemostasis. 72
Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients 72
More on aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm. 71
METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID 71
PGE2 released by pancreatic cancer cells undergoing ER stress transfers the stress to DCs impairing their immune function 71
Dual Antiplatelet Therapy in Neuroendovascular Procedures 70
Influenza della Rosuvastatina sull’attività antiaggregante del Clopidogrel nei pazienti con Sindrome Coronarica Acuta 69
The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding 69
Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis 69
Thromboxane Production in Morbidly Obese Subjects 68
Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention: Results of the ISAR-ASPI Registry 68
Red and white wine differently affect collagen-induced platelet aggregation. 68
Interindividual variability of platelet sensitivity to aspirin is due to impaired platelet COX-1/Aspirin interaction 67
Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents 67
MECHANISMS OF THE PLATELET PROAGGREGATING ACTIVITY OF HUMAN CARCINOMA A431 CELLS 67
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 67
Platelet activation and cytokine production during hypothermic cardiopulmonary bypass. A possible correlation? 67
SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke 67
Effects of storage on in vitro platelet responses: Comparison of ACD and Na citrate anticoagulated samples 66
Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase. 65
Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin 65
Letter by Iannuccelli et al Regarding Article, "paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients with Recent Ischemic Stroke" 65
Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine 64
Aspirin Extrusion From Human Platelets Through Multidrug Resistance Protein-4-Mediated Transport Evidence of a Reduced Drug Action in Patients After Coronary Artery Bypass Grafting 64
Synergism among flavonoids in inhibiting platelet aggregation and H2O2 production 63
Shape change is independent of tyrosine phosphorylation of p130 in human platelets 63
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O-2(-) production 63
Medicina di laboratorio - La diagnosi di malattia nel laboratorio clinico: collaborazione traduzione 63
Protein kinase C activation is not a key step in ADP-mediated exposure of fibrinogen receptors on human platelets. 62
The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide 61
Effects of picotamide on the calcium mobilization and phospholipase C activation in human platelets. 61
Evidence for platelet alphaIIb/beta3 activation despite elevated cytosolic cAMP. 61
Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide 61
Prevalence of allo-immunization anti-HLA and anti-integrin alpha IIb beta 3 in Glanzmann thromboasthenia patients 60
Hydrogen peroxide is involved in collagen-induced platelet activation 60
Platelet signalling: cAMP and cGMP 60
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 60
Proinflammatory cytokines and hemostatic system in patients with chronic obstructive pulmonary disease 59
Increased superoxide anion production by platelets in hypercholesterolemic patients 59
Effect of Heparanase inhibitor on Tissue Factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies 59
Totale 8.516
Categoria #
all - tutte 31.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 180
selected - selezionate 0
volume - volumi 0
Totale 31.794


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020233 0 0 0 0 0 0 0 0 0 111 76 46
2020/2021699 56 69 43 89 28 91 13 51 76 100 44 39
2021/20221.649 23 100 143 52 177 79 67 174 136 121 296 281
2022/20231.842 292 336 181 193 201 163 20 134 176 20 87 39
2023/20241.031 59 136 65 73 110 226 52 55 3 106 70 76
2024/20251.423 91 156 85 124 110 160 197 110 387 3 0 0
Totale 10.077